Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCK2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
mRNA | C9orf135 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
mRNA | ZNF433 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | TGFB1I1 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
mRNA | ATP6V0B | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | LCN15 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | CXorf23 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
mRNA | ABCC10 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
mRNA | NEXN | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
mRNA | LBR | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |